Just musing here. IF the OnCarlytics/Blincyto trial yields great outcome for the patients, ie CRs and strong PRs, would Amgen decides:
'Nope, we don't want anything to do with treating 90% of the solid cancer market'
or
'FECK! Let's BUY Imugene or BEG them to give us a deal'
Which is the most likely scenario? And I stress again, only IF the trial outcome is successful.
And then of course there is that OnCarlytics/Azer-cel trial. If is successful, then whoever comes after that to do a deal will literally have to go on their knees to beg IMU to throw a bit of bone over to them for IMU won't really need any of them anymore by then. In view of that, I believe if the above OnCarlytics/Blincyto successful scenario were to come to pass, I bet Amgen would not wait nor hesitate to ring IMU. In fact, they might panic if IMU did not pick up the phone quick enough
OK, musing over
- Forums
- ASX - By Stock
- IMU
- Ann: Phase 1 onCARlytics Trial Advances to Combination Arm
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm, page-93
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.5¢ |
Change
0.001(1.85%) |
Mkt cap ! $395.2M |
Open | High | Low | Value | Volume |
5.5¢ | 5.6¢ | 5.2¢ | $764.2K | 14.09M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 473580 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 2433387 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 192794 | 0.054 |
17 | 1435989 | 0.053 |
23 | 2223132 | 0.052 |
27 | 3470800 | 0.051 |
71 | 4011536 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 1907103 | 12 |
0.056 | 2634139 | 9 |
0.057 | 1129800 | 7 |
0.058 | 1452579 | 7 |
0.059 | 908150 | 7 |
Last trade - 10.34am 28/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |